Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction

Kardiol Pol. 2023;81(4):327-329. doi: 10.33963/KP.a2023.0087.

Authors

Dan Atar^{1

2}, Arnhild Bakken¹, John Munkhaugen^{3

4}

Affiliations

¹ Department of Cardiology, Oslo University Hospital Ulleval, Oslo Norway.
² Institute of Clinical Medicine, University of Oslo, Norway.
³ Department of Medicine, Drammen Hospital, Drammen, Norway.
⁴ Department of Behavioral Medicine, University of Oslo, Norway.

PMID: 37144720
DOI: 10.33963/KP.a2023.0087

No abstract available

Publication types

Editorial

MeSH terms

Humans
Hypolipidemic Agents / therapeutic use
Lipids
Myocardial Infarction* / drug therapy
Survivors

Substances

Hypolipidemic Agents
Lipids